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Sexually transmitted infections (STI), such as Chlamydia trachomatis, Neisseria
gonorrhoeae, Herpes Simplex Virus (HSV), and Treponema pallidum, are common causes
of proctitis among gay men and other men who have sex with men (MSM) [1, 2].
Inflammatory proctitis caused by an STI may increase the susceptibility and infectivity of
HIV[3, 4]. In many cases of proctitis, however, no etiological organism is detected[1]. The
advent of nucleic acid amplification techniques (NAATs) presents an opportunity to detect
organisms previously difficult to isolate from the rectum. Two such organisms, Trichomonas
vaginalis and Mycoplasma genitalium, have been implicated in male urethritis, female
cervicitis and endometrial infection[5-11].
M. genitalium is a small bacterium that was difficult to identify until the development of the
polymerase chain reaction (PCR) technique in the 1991[12, 13]. Though studies have
detected M. genitalium from the urethra of MSM[14, 15], only one study investigated M.
genitalium in the rectum by PCR[16], yet a correlation with rectal symptoms was not
reported. Recently, a comparison of multitarget real-time PCR and a transcription-mediated
amplification (TMA) research assay found both assays to be highly accurate in the detection
of M. genitalium from male urine and female vaginal swabs[17].
T. vaginalis is a common curable STI worldwide, causing an estimated 174 million new
cases annually[18]. Conventional methods for detection include culture or microscopic
visualization on vaginal wet preparation; both require live organisms for accuracy and have
modest sensitivity. The development of NAATs has increased case detection[19]: in a recent
study that investigated accuracy of the T. vaginalis culture, PCR and TMA, both TMA and
PCR detected significantly more T. vaginalis infections than culture[20].
Identifying the etiological causes of proctitis is important in order to deliver appropriate
treatment and decrease the risk for HIV transmission. This study explored the rectal
prevalence of T. vaginalis and M. genitalium in a population of MSM in San Francisco, and
examined their role in symptomatic and asymptomatic rectal infection.
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This was a cross-sectional pilot study of 500 consecutive rectal specimens collected at the
San Francisco municipal STD clinic from November 11, 2005 to January 4th, 2006. As per
current standard of care, all MSM who reported receptive anal sex within six months prior to
their clinic visit were screened for N. gonorrhoeae and C. trachomatis by TMA (Aptima
Combo2, Gen-Probe, San Diego, USA), validated by the San Francisco Department of
Public Health Laboratory for rectal swabs[21]. MSM with rectal symptoms (i.e., rectal
pruritus, pain, tenesmus, bleeding or discharge) were evaluated by anoscopy and tested for
N. gonorrhoeae and C. trachomatis by TMA and HSV by PCR[22]. Rectal discharge was
evaluated by Gram stain on-site and the diagnosis of proctitis was made by the presence of
one or more polymorphonuclear neutrophils per high-powered field. HIV positive patients
are not offered HIV testing; therefore HIV status was determined either by patient report or
the result of HIV testing records at the San Francisco municipal STD clinic. During the time
period of the study, initial reactive enzyme immunoassays were tested in duplicate
(Vironostika HIV-1 Microelisa, bioMerieux Inc., Durham, NC) and confirmed by
Fluorognost HIV-1 IFA (Sanochemia Pharmazeutika, Vienna, Austria). All MSM were
routinely screened for syphilis by Venereal Disease Research Laboratory test.
All C. trachomatis and N. gonorrhoeae TMA swab specimens were routinely sent to the San
Francisco Department of Public Laboratory for testing. For the purpose of this study,
aliquots of the remnant rectal specimens were de-identified and sent to the Johns Hopkins
University International Sexually Transmitted Diseases Research Laboratory for batched
testing by research TMA assays for M. genitalium and T. vaginalis (analyte-specific reagent,
Gen-Probe, San Diego, USA)[17, 20]. The cutoff for a positive reaction was 40,000 relative
light units for the M. genitalium assays and 60,000 relative light units for the T. vaginalis
assays. We used the initial positive tests for our analysis; however, since neither the M.
genitalium nor T. vaginalis assays have been validated previously for the rectal site, positive
tests with sufficient specimen were repeat tested once by TMA and again by a research
PCR[17, 20]. Non-identifying, patient information from electronic records was reviewed for
the analysis. The University of California, San Francisco’s and Johns Hopkins’ human
subjects committees approved this project as exempt for human subject consideration.
Frequencies and logistic regression were performed by STATA (Version 9). Age and
selected patient characteristics with a p-value less than 0.10 in the univariate analysis were
included in the multivariate model. The strength of statistical association was determined by
proximity to an alpha level of 0.05.
We detected 27 (5.4%) positive rectal specimens for M. genitalium, 3 (0.6%) for T.
vaginalis, 50 (10%) for C. trachomatis, and 57 (11.4%) for N. gonorrhoeae. Forty specimens
(8.0%) were from patients with rectal symptoms, and 26 specimens (5.2%) were from
patients whom were diagnosed with proctitis.
Of the 27 positive rectal specimens for M. genitalium, 23 of 24 (95.8%) available specimens
were repeatedly positive by TMA, and 17 of 25 (68.0%) tested positive by PCR. Three
specimens from the asymptomatic patients were initially positive for T. vaginalis; however,
only one of three specimens was repeatedly positive by TMA and all three specimens were
negative by research PCR.
Results from the univariate and multivariate analysis of factors associated with M.
genitalium are displayed in the Table. In the univariate analysis, positive HIV status (OR
3.1, 95% CI 1.4-6.9) and C. trachomatis (OR 3.5, 95% CI 1.4-8.7) co-infection were
strongly associated with M. genitalium infection. Rectal symptoms (OR 2.8, 95% CI
1.0-8.0) and proctitis ( 2.4, 95% CI 0.7-8.7) were weakly associated with M. genitalium
infection. In the multivariate analysis, only positive HIV status remained strongly associated
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with M. genitalium infection. After controlling for confounding, a strong association emerge
association between younger age and M. genitalium (test for trend, p=0.051).
Specimens included 26 from patients who were diagnosed with clinical proctitis. Fifteen
(58%) of 26 specimens had an organism identified (Figure). Of note, no specimens from
patients with proctitis tested positive for T. vaginalis. Three specimens (12%) from patients
with proctitis tested positive for M. genitalium. Of these three patients, two were co-infected
with C. trachomatis and one was co-infected with Herpes Simplex Virus, Type 1. Because
all three positive specimens for M. genitalium in patients with proctitis had other co-
infections, M. genitalium identification did not increase the number of cases of proctitis with
an identified pathogen.
The advent of molecular amplification testing continues to advance our understanding of
STIs and their clinical syndromes. We tested 500 rectal specimens collected from MSM and
found a M. genitalium prevalence of 5%. Rectal M. genitalium was strongly associated with
HIV status, and weakly associated with rectal symptoms or clinical proctitis. The association
between positive HIV status and M. genitalium may be explained by the frequency of
exposure resulting from increased unprotected anal sex in MSM who are HIV-infected in
San Francisco[23]. HIV-infected patients not using condoms for receptive anal sex would be
at higher risk of M. genitalium exposure and infection. Though this pilot study shows a
weak association between M. genitalium and rectal symptoms or clinical proctitis, a study
with a higher number of events may reveal a stronger association for this trend.
We also evaluated the role of M. genitalium and T. vaginalis in the etiology of clinical
proctitis. In a study of a similar population in San Francisco, Klausner and colleagues found
no etiological organism was identified in 45% of clinical proctitis cases[1]. That proportion
of unknown etiology was similar to the proportion of unknown etiology in our study.
According to our study, neither M. genitalium nor T. vaginalis explained any more cases of
symptomatic proctitis than C. trachomatis, N. gonorrhoeae, HSV, or syphilis.
Only one of 500 samples repeatedly tested positive for T. vaginalis by TMA, and this case
tested negative by PCR. Though the TMA may be more sensitive than the PCR, a
prevalence of 0.2% in this high risk STI sample is low. It is unlikely that T. vaginalis
colonizes the rectum. The lack of detection of rectal T. vaginalis in our large sample of
specimens from a high risk population supports the reported concept of site specificity [24].
Though evaluating the sensitivity and specificity M. genitalium and T. vaginalis TMA
assays in rectal specimens was not an objective of this study, prior validation studies have
not been done. The small number of T. vaginalis specimens in our study continues to
preclude us from this analysis. For samples with sufficient specimen, 95.8% of initial M.
genitalium positives were confirmed with a second assay. Those samples that were TMA
positive and PCR negative may represent an increase in sensitivity of TMA, or TMA false
positives.
In conclusion, though it is likely that M. genitalium infects the rectum, it is unclear if is
contributes to clinical syndromes. However, asymptomatic infections could be an important
reservoir for continued spread of STIs, as well as increased HIV transmission. More
research should be undertaken to better understand rectal infection by M. genitalium, as well
as other inflammatory causes of proctitis.
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Figure.
Frequency of diagnosis of sexually transmitted infections in men who have sex with men
with proctitis (n = 26 San Francisco municipal STD clinic, 2005-2006
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Table
Unadjusted and adjusted odds ratios for rectal specimens positive for M. genitalium, San Francisco municipal
STD clinic, 2005-2006.
Variable Prevalent Unadjusted Adjusteda
M. genitalium
Infection
n/N (%) OR (95% CI) p-valueb OR (95% CI) p-valueb
Total N = 500 27/500 (5.4%)
p= .356 p= .147
Age
p=.186c p= .051c
   < 20 years 3/18 (16.7%) 3.9 (1.0-15.3) 6.8 (1.5-30.5)
   20 to 24 years 4/69 (5.8%) 1.2 (0.4-3.9) 1.7(0.5-5.8)
   25 to 34 years 8/167 (4.8%) 1.0 (0.4-2.5) 1.1 (0.4-2.8)
   > 35 years 12/246 (4.9%) 1 1
Race p= .610 p= .390
   White 12/269 (4.5%) 1 1
   Black 2/38 (5.3%) 1.2 (0.3-5.5) 0.9 (0.7-4.3)
   Latino 7/125 (5.6%) 1.3 (0.5-3.3) 1.0 (0.4-2.7)
   API/ Native
6/68 (8.8%) 2.1 (0.7-5.7) 2.6 (0.9-7.7)
   American
HIV Status p= .005 p= .010
   Uninfected 13/359 (3.6%) 1 1
14/133
   Infected 3.1 (1.4-6.9) 3.2 (1.3-7.8)
(10.5%)
Rectal symptomsd p= .070 p= .353
   No 22/460 (4.8%) 1 1
   Yes 5/40 (12.5%) 2.8 (1.0-8.0) 1.7 (0.6-5.3)
Proctitise p= .209 p= .699
   No 24/474 (5.1%) 1 1
   Yes 3/26 (11.5%) 2.4 (0.7-8.7) 0.66 (0.1-5.3)
C. trachomatis, rectal p= .014 p= .115
   Negative 20/450 (4.4%) 1 1
   Positive 7/50 (14.0%) 3.5 (1.4-8.7) 2.3 (0.9-6.1)
N. gonorrhea, rectal p= .580 p= .947
   Negative 23/443 (5.2%) 1 1
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Variable Prevalent Unadjusted Adjusteda
M. genitalium
Infection
n/N (%) OR (95% CI) p-valueb OR (95% CI) p-valueb
   Positive 4/57 (7.0%) 1.4 (0.5-4.1) 1.0 (.32-3.4)
T. vaginalis, rectal
   Negative 27/497 (5.4%)
   Positive 0/3 No observations No observations
Herpes Simplex Virus,
p= .245
Type 1 or 2f
   Negative 1/26 (3.9%) 1
   Positive 1/5 (20%) 6.3 (0.3-121.3)
Early syphilis p= .615 p= .846
   No 26/489 (5.3%) 1
   Yes 1/11 (9.1%) 1.78 (0.2-14.4) 1.3 (0.1-10.9)
aAll factors were adjusted for age, HIV status, rectal symptoms, and rectal chlamydia
b
Likelihood ratio test
c
Test for trend
d
Rectal symptoms were defined as a history of rectal pain, bleeding, discharge or tenesmus.
e
Proctitis was diagnosed as the presence of one or more neutrophils under high powered field and oil-immersion.
f
HSV 1 and 2 specimens for PCR were collected for symptomatic patients only. There were not enough events to enter HSV 1 and 2 into the
multivariate model.
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